Aberrant EphB/ephrin-B expression in experimental gastric lesions and tumor cells

doi:10.3748/wjg.v21.i2.453

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 2

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6239)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-8) series.

Item

Count

PDF

471

WORD

278

HTML

3380

Figures (1-8)

202

Sum=4331

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

955

Download

953

Sum=1908

Jan 14, 2015 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (8)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastroenterol. Jan 14, 2015; 21(2): 453-464
Published online Jan 14, 2015. doi: 10.3748/wjg.v21.i2.453

Full Size Figure Download Figure

Figure 8 EphB and ephrin-B mRNA expression in human gastric carcinoma cell lines. Transcript levels in AZ-521, KATO-III, MKN-7, and SH-10-TC cells were determined by reverse transcription-polymerase chain reaction. All cell lines coexpressed more than one EphB receptor and/or ephrin-B ligand at a high level.

Citation: Uchiyama S, Saeki N, Ogawa K. Aberrant EphB/ephrin-B expression in experimental gastric lesions and tumor cells. World J Gastroenterol 2015; 21(2): 453-464
URL: https://www.wjgnet.com/1007-9327/full/v21/i2/453.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i2.453